Evidence: US Healthcare, Third Leading Cause of Death_Institute of Medicine, JAMA, 2000
Click here for full article
Click here for full article
Pfizer’s smoking cessation drug, Chantix (varenicline), may be the most dangerous drug ever to carry the government seal of approval–it poses a danger, not just to those who ingest the drug, but to people in the community in which they live.
Practice Guidelines: Can We Trustthe Evidence in Evidence-Based Medicine? Sun, 25 Sep 2005 “Research and Clinical Practice Guidelines: Can We Trust the Evidence in Evidence-Based Medicine?” is an article by Dr. John Abramson* (Harvard) and Dr. Barbara Starfeld (Distinguished Professor, Johns Hopkins), published in the Journal of the American Board…
Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings.
A sensational investigative report by by Harriet Ryan, Lisa Girion and Scott Glover in the Los Angeles Times (May 5, 2016) exposes the irresponsible, corrupt practices of Purdue Pharmaceuticals, the company that manufactures and aggressively markets OxyContin at a dosing schedule that some doctors have described as “an addiction producing machine.”…
LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer Prize winner David Willman of the Los Angeles Times, whose investigative reporting first revealed the major covert conflicts of interest among top scientists and administrators at the National Institutes of Health (NIH), reports…
Curt D. Furberg, MD, an internationally recognized cardiovascular epidemiologist with expertise in clinical trials, drug safety and public health. Dr. Furberg is a Professor Emeritus of Public Health Sciences at Wake Forest University who has chaired NIH’s Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Steering Committee and has…